Preoperative Prasugrel Discontinuation Management in Coronary Artery Surgery

Mate Petricevic; Bojan Biocina; Martina Zrno Mihaljevic; Marko Boban; Jure Samardzic; Sanja Konosic; Visnja Ivancan

doi:10.1055/s-0034-1390156

The Thoracic and Cardiovascular Surgeon, Table of Contents

Thorac Cardiovasc Surg 2015; 63(01): 036-038
DOI: 10.1055/s-0034-1390156

Letter to the Editor

Georg Thieme Verlag KG Stuttgart · New York

Preoperative Prasugrel Discontinuation Management in Coronary Artery Surgery

Authors

Mate Petricevic

¹Department of Cardiac Surgery, University of Zagreb School of Medicine, University Hospital Center Zagreb, Zagreb, Croatia
Bojan Biocina

¹Department of Cardiac Surgery, University of Zagreb School of Medicine, University Hospital Center Zagreb, Zagreb, Croatia
Martina Zrno Mihaljevic

¹Department of Cardiac Surgery, University of Zagreb School of Medicine, University Hospital Center Zagreb, Zagreb, Croatia
Marko Boban

²Department of Cardiology, Medical School University of Osijek and Rijeka, Opatija, Croatia
Jure Samardzic

³Department of Cardiovascular Diseases, University of Zagreb School of Medicine, University Hospital Center Zagreb, Zagreb, Croatia
Sanja Konosic

⁴Department of Anesthesiology, University of Zagreb School of Medicine, University Hospital Center Zagreb, Zagreb, Croatia
Visnja Ivancan

⁴Department of Anesthesiology, University of Zagreb School of Medicine, University Hospital Center Zagreb, Zagreb, Croatia

Abstract

All articles of this category

Full Text

References

References
1 Drews S, Bolliger D, Kaiser C , et al. Prasugrel increases the need for platelet transfusions and surgical reexploration rates compared with clopidogrel in coronary artery bypass surgery. Thorac Cardiovasc Surg 2014; [epub ahead of print]. doi: 10.1055/s-0034-1373901
2 Dyke C, Aronson S, Dietrich W , et al. Universal definition of perioperative bleeding in adult cardiac surgery. J Thorac Cardiovasc Surg 2014; 147 (5) 1458 , e1
3 Petricevic M, Kopjar T, Biocina B , et al. The predictive value of platelet function point-of-care tests for postoperative blood loss and transfusion in routine cardiac surgery: a systematic review. Thorac Cardiovasc Surg 2014; [epub ahead of print]. doi: 10.1055/s-0034-1378191
4 Petricevic M, Biocina B, Milicic D , et al. Bleeding risk assessment using multiple electrode aggregometry in patients following coronary artery bypass surgery. J Thromb Thrombolysis 2013; 35 (1) 31-40
5 Price MJ, Walder JS, Baker BA , et al. Recovery of platelet function after discontinuation of prasugrel or clopidogrel maintenance dosing in aspirin-treated patients with stable coronary disease: the recovery trial. J Am Coll Cardiol 2012; 59 (25) 2338-2343
6 Awidi A, Saleh A, Dweik M , et al. Measurement of platelet reactivity of patients with cardiovascular disease on-treatment with acetyl salicylic acid: a prospective study. Heart Vessels 2011; 26 (5) 516-522
7 Ferraris VA, Ferraris SP, Joseph O, Wehner P, Mentzer Jr RM. Aspirin and postoperative bleeding after coronary artery bypass grafting. Ann Surg 2002; 235 (6) 820-827

References
1 Drews S, Bolliger D, Kaiser C , et al. Prasugrel increases the need for platelet transfusions and surgical reexploration rates compared with clopidogrel in coronary artery bypass surgery. Thorac Cardiovasc Surg 2014; [epub ahead of print]. doi: 10.1055/s-0034-1373901
2 Dyke C, Aronson S, Dietrich W , et al. Universal definition of perioperative bleeding in adult cardiac surgery. J Thorac Cardiovasc Surg 2014; 147 (5) 1458-1463 , e1
3 Kozek-Langenecker SA, Afshari A, Albaladejo P , et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol 2013; 30 (6) 270-382
4 Petricevic M, Kopjar T, Biocina B , et al. The predictive value of platelet function point-of-care tests for postoperative blood loss and transfusion in routine cardiac surgery: A systematic review. Thorac Cardiovasc Surg 2014; [epub ahead of print]
5 Franken CC, Kaiser AF, Krüger JC, Overbeck K, Mügge A, Neubauer H. Cytochrome P450 2B6 and 2C9 genotype polymorphism—a possible cause of prasugrel low responsiveness. Thromb Haemost 2013; 110 (1) 131-140